1. Home
  2. AKTX vs WVVI Comparison

AKTX vs WVVI Comparison

Compare AKTX & WVVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Akari Therapeutics plc ADS

AKTX

Akari Therapeutics plc ADS

HOLD

Current Price

$0.26

Market Cap

14.4M

Sector

Health Care

ML Signal

HOLD

Logo Willamette Valley Vineyards Inc.

WVVI

Willamette Valley Vineyards Inc.

HOLD

Current Price

$3.05

Market Cap

13.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
AKTX
WVVI
Founded
N/A
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Beverages (Production/Distribution)
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
14.4M
13.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AKTX
WVVI
Price
$0.26
$3.05
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$3.30
N/A
AVG Volume (30 Days)
2.3M
7.7K
Earning Date
11-13-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$37,366,837.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.22
$2.49
52 Week High
$1.73
$7.18

Technical Indicators

Market Signals
Indicator
AKTX
WVVI
Relative Strength Index (RSI) 31.66 56.14
Support Level $0.22 $2.71
Resistance Level $0.47 $2.98
Average True Range (ATR) 0.05 0.17
MACD 0.00 0.03
Stochastic Oscillator 18.04 50.64

Price Performance

Historical Comparison
AKTX
WVVI

About AKTX Akari Therapeutics plc ADS

Akari Therapeutics PLC is an oncology company developing next-generation antibody-drug conjugates (ADCs) designed around novel, proprietary cancer-killing toxins (payloads). The company believes these novel payloads may have the potential to transform the efficacy and safety outcomes of ADCs as cancer therapies beyond options that are currently available or in development. Its lead product candidate is AKTX-101, a preclinical stage Trop2-targeting ADC that combines PH1 with the Trop2 antibody, which is expressed in the highest number of solid tumor cancer types, including lung, breast, colon and prostate.

About WVVI Willamette Valley Vineyards Inc.

Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.

Share on Social Networks: